The recommendations listed in this clinical practice guideline are, whenever possible,
evidence-based. An initial extensive evidence review, which included literature derived from …

Ventricular arrhythmias are an important cause of morbidity and mortality and come in a
variety of forms, from single premature ventricular complexes to sustained ventricular …

Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …

Catheter ablation is now an important option to control recurrent ventricular tachycardias
(VTs). The field has evolved rapidly and is a work in progress. Ablation is often a sole …

There is increasing evidence regarding the prevalence of genetic cardiomyopathies, for
which arrhythmias may be the first presentation. Ventricular and atrial arrhythmias …

Although implantable cardioverter-defibrillators positively affect survival in patients at
increased risk for arrhythmic sudden cardiac death, quality of life can be negatively affected …

Abbreviations: 3D, three-dimensional; AF, atrial fibrillation; AP, accessory pathway; ARVC,
arrhythmogenic right ventricular cardiomyopathy; AT, atrial tachycardia; AVB, atrioventricular …

Background—Patients with left ventricular dysfunction have an elevated risk of sudden
cardiac death. However, the substrate for ventricular arrhythmia in patients with nonischemic …

ablation of scar-related left ventricular (LV) tachycardias. The risk is likely greater in the thin-
walled right ventricle (RV) and with power 40 W. External irrigation has been suggested to …

Purkinje‐related monomorphic ventricular tachycardias (VTs) can be classified into four
distinct groups:(1) verapamil‐sensitive left fascicular VT,(2) Purkinje fiber‐mediated VT post …